BioSpace News Archive

Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison’s Highly Qualified Nominees at Upcoming Annual Meeting

Failures at Knight have been exposed by multiple, independent third parties

April 29, 2019
·
14 min read
Policy

/R E P E A T -- CFIA Media Advisory - Opening of the African Swine Fever Forum/

The Honourable Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, and Under Secretary of Agriculture Greg Ibach, on behalf of Secretary of Agriculture Sonny Perdue, open the African Swine Fever Forum

April 29, 2019
·
1 min read
Policy

LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion for First-Line Maintenance Treatment in BRCA-Mutated Advanced Ovarian Cancer

AstraZeneca and Merck’s LYNPARZA Is the Only PARP Inhibitor in This Setting to Demonstrate an Improvement in Progression-Free Survival for Patients Who Responded to Platinum-Based Chemotherapy

April 29, 2019
·
17 min read
Business

HealthSource Salutes Military with Free Care

May is Military Appreciation Month, established to remind Americans of the important role U.S. Armed Forces have played in the history and development of our country.

April 29, 2019
·
3 min read
Job Trends

US Biopharma Company Undertakes Anti-Cancer Clinical Trials in Poland, First Patient Showing Positive Initial Treatment - April 29, 2019

Moleculin quickly recruited qualified patients and started trials for two of its portfolio drugs to supplement US efforts.

April 29, 2019
·
6 min read
First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study

Christian Lattermann, M.D., Chief of the Sports Medicine Service and Director of the Center for Cartilage Repair at Brigham and Women’s Hospital in Boston, recently became the first surgeon in New England to enroll a patient in CartiHeal’s FDA – IDE study.

April 29, 2019
·
1 min read
Deals

OTC Markets Group Welcomes Beroni Group Ltd. to OTCQX

OTC Markets Group Inc. announced Beroni Group Ltd., an international biotechnological company, has qualified to trade on the OTCQX® Best Market.

April 29, 2019
·
3 min read
FDA

Finch Therapeutics Receives Fast Track Designation for the Investigation of Full-Spectrum Microbiota as a Treatment for Children with Autism Spectrum Disorder

Finch Therapeutics Group, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation to its Full-Spectrum Microbiota® therapy for the treatment of children with Autism Spectrum Disorder.

April 29, 2019
·
3 min read
Business

Concert Pharmaceuticals Names Jesper Høiland to its Board of Directors

Concert Pharmaceuticals, Inc. announced that Jesper Høiland has been appointed to its Board of Directors and will serve as a member of its Compensation Committee, effective immediately.

April 29, 2019
·
2 min read
Policy

Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV

If approved, the rilpivirine and cabotegravir regimen would be the first-ever long-acting injectable treatment for adults living with HIV

April 29, 2019
·
12 min read